In late May, the Urology, Andrology, Nephrology 2016 conference was held in Kharkiv, Arterium Corporation being the primary sponsor. About 300 participants from 8 countries attended the event, including urologists, nephrologists, paediatric surgeons and oncologists.

On May 25, presentation of Farhad and Shirin, a newly published poem by the prominent Central Asian writer and philosopher of 15th century Ali-Shir Nava'i, was held at the embassy of Republic of Uzbekistan in Ukraine.

Galychpharm (Arterium Corporation), has launched a new line for production of infusion solutions. The company got a license for infusion production in December 2015, making first solution batches as early as in March 2016.

The urgent introduction of special qualification requirements (WHO prequalification *) and involvement of international organizations in the government procurement of drugs and medical supplies is currently a subject of intense public debates. Being a leader in the Ukrainian pharmaceutical market, Arterium Corporation deems it necessary to share its opinion on this matter.

Arterium Corporation keeps expanding its portfolio of the medicinal products used in endocrinology. In September, the company launched genetically engineered insulins under the trade names Insular Activ and Insular Stabil. Arterium Corporation thus added two new medicinal products to its product range: Insular Activ (3 ml cartridges, 5 cartridges per a carton; 5 ml vials, 5 vials per a carton) and Insular Stabil (3 ml cartridges, 5 cartridges per a carton; 5 ml vials, 5 vials per a carton).

Arterium Corporation has enhanced its product portfolio with a new presentation of Resistol—oral drops 50 ml. The new and larger presentation is for a complete course of treatment of acute and chronic infections of the respiratory tract and nasopharynx (bronchitis, tonsillar angina, sinusitis, rhinopharyngitis) in adults and children.